Home / Etolid Tablet
Etolid Tablet

Etolid Tablet

(0 customer reviews)

$0.32 / unit

Available Options

Pack SizePricePrice / UnitQuantityAction
180 Tablets$56.88$0.32/unit
150 Tablets$47.40$0.32/unit
120 Tablets$37.92$0.32/unit
90 Tablets$28.44$0.32/unit
60 Tablets$18.96$0.32/unit
30 Tablets$9.48$0.32/unit
Looking for bulk / B2B pricing?

Product Description

ETOLID TABLET

Brand Name: Etolid Tablet
Generic Name: Etodolac
Strength: 600 mg
Dosage Form: Oral Film-Coated Extended-Release Tablet
Therapeutic Class: Nonsteroidal Anti-Inflammatory Drug (NSAID) / Analgesic / Anti-Inflammatory Medicine
Manufacturer / Marketer: Leeford Healthcare Limited
Pack Size: 1 × 10 Tablets

What is this medicine?

ETOLID TABLET contains Etodolac 600 mg, a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, swelling, and stiffness associated with certain joint and musculoskeletal conditions.

Etodolac works by inhibiting cyclooxygenase (COX) enzymes involved in prostaglandin production. Prostaglandins are chemical substances that contribute to pain, inflammation, and swelling.

By reducing prostaglandin synthesis, etodolac helps relieve joint discomfort, decrease inflammation, and improve mobility.

Etolid Tablet is formulated as an extended-release tablet, designed to release the active ingredient gradually over time and provide sustained pain relief.

This medicine is commonly used for:

  • Osteoarthritis

  • Rheumatoid arthritis

  • Chronic inflammatory joint pain

  • Joint swelling and stiffness

  • Pain associated with inflammatory musculoskeletal disorders

  • Painful joint conditions affecting mobility

  • Symptomatic management of arthritis-related discomfort

  • Improvement of movement restricted by joint pain and inflammation

NOTE: Etolid Tablet provides symptomatic relief but does not cure arthritis or prevent progression of the underlying joint disease.

The 600 mg extended-release formulation is primarily intended for the management of arthritis-related pain and inflammation. It should not be substituted directly for immediate-release etodolac or other NSAIDs without medical advice.

Etolid Tablet contains etodolac alone and should not be confused with Etolid MR Tablet, which additionally contains thiocolchicoside.

What should I tell my health care provider before I take this medicine?

They need to know if you have any of these conditions:

  • Allergy to etodolac or any ingredient of the tablet

  • Allergy to aspirin or other NSAIDs

  • Asthma or allergic reactions triggered by aspirin or NSAIDs

  • History of severe skin reactions to medicines

  • Active stomach or intestinal ulcers

  • Previous gastrointestinal bleeding

  • History of gastrointestinal perforation

  • Inflammatory bowel disease

  • Heart disease or previous heart attack

  • History of stroke

  • Heart failure

  • High blood pressure

  • Kidney disease or reduced kidney function

  • Liver disease or impaired liver function

  • Severe dehydration

  • Fluid retention or swelling of the legs

  • Bleeding disorders

  • High cholesterol

  • Diabetes

  • Smoking or other cardiovascular risk factors

  • Pregnancy or planning pregnancy

  • Breastfeeding

  • Use of blood-thinning medicines

  • Use of other NSAID pain relievers

  • Planned heart bypass surgery

  • Older age or increased risk of medicine-related complications

Inform your healthcare provider about all prescription medicines, nonprescription medicines, vitamins, supplements, and herbal products you currently take.

Important: Etodolac may increase the risk of serious cardiovascular events, including heart attack and stroke, as well as gastrointestinal bleeding, ulcers, and perforation.

These complications may occur without warning, particularly in older adults and patients with existing risk factors.

Etodolac should not be used for pain associated with coronary artery bypass graft (CABG) surgery.

How should I use this medicine?

Take this medicine exactly as prescribed by your healthcare provider.

  • Swallow the extended-release tablet whole with a glass of water.

  • Do not crush, chew, or split the tablet.

  • Take the medicine with food or milk if stomach discomfort occurs.

  • Etodolac extended-release tablets are generally taken once daily.

  • Take the medicine at approximately the same time every day.

  • Follow the prescribed dosage and duration.

  • Do not increase or decrease the dose without medical advice.

  • Do not combine it with other NSAIDs unless specifically directed by your doctor.

  • Avoid prolonged treatment without medical supervision.

  • Maintain adequate hydration.

  • Monitor blood pressure if recommended.

  • Inform your doctor if pain or inflammation persists or worsens.

  • Attend follow-up appointments when necessary.

Usual Adult Dose: Etodolac extended-release tablets may be prescribed at 400–1000 mg once daily for osteoarthritis or rheumatoid arthritis, depending on individual clinical requirements and available tablet strengths.

Etolid Tablet Strength: Each Etolid extended-release tablet contains 600 mg of etodolac. The number of tablets and dosing schedule should be determined by the treating physician.

Maximum Recommended Daily Dose: For extended-release etodolac, the usual maximum recommended adult dose is 1000 mg daily under applicable prescribing information. Higher doses should not be assumed safe.

Older Adults: Lower doses and careful monitoring may be necessary because older adults are more susceptible to gastrointestinal bleeding, kidney problems, and other NSAID-related complications.

Duration of Treatment: Depends on the underlying condition, severity of symptoms, treatment response, and individual risk factors. Long-term treatment requires periodic medical reassessment.

Expected Results: Pain and inflammation may begin improving during the early treatment period. The full therapeutic benefit in chronic arthritis may require continued treatment over several days or weeks.

Overdosage: Seek immediate medical attention if an overdose is suspected. Symptoms may include severe nausea, vomiting, abdominal pain, dizziness, drowsiness, gastrointestinal bleeding, breathing difficulties, or kidney dysfunction.

NOTE: Etolid Tablet contains etodolac in an extended-release formulation. The tablet must not be crushed or chewed because this may alter the intended drug-release characteristics.

Use the lowest effective dose for the shortest clinically appropriate duration.

What if I miss a dose?

  • Take the missed dose as soon as you remember.

  • If it is nearly time for your next scheduled dose, skip the missed dose.

  • Continue with your regular dosing schedule.

  • Do not take two doses together to compensate for a missed dose.

  • Avoid taking extra tablets without medical advice.

  • Contact your healthcare provider if you frequently miss doses or are uncertain about your treatment schedule.

Important: Taking excessive doses of etodolac increases the risk of gastrointestinal bleeding, kidney injury, and cardiovascular complications without necessarily improving pain relief.

What may interact with this medicine?

Etodolac may interact with medicines that affect blood clotting, kidney function, blood pressure, or drug metabolism.

Potential interactions include:

  • Aspirin

  • Ibuprofen

  • Diclofenac

  • Naproxen

  • Other nonsteroidal anti-inflammatory drugs

  • Warfarin and other anticoagulants

  • Clopidogrel and other antiplatelet medicines

  • ACE inhibitors, including ramipril and enalapril

  • Angiotensin receptor blockers, including losartan and valsartan

  • Diuretics, including furosemide and hydrochlorothiazide

  • Lithium

  • Methotrexate

  • Cyclosporine

  • Tacrolimus

  • Corticosteroids, including prednisolone

  • Selective serotonin reuptake inhibitors (SSRIs)

  • Serotonin-norepinephrine reuptake inhibitors (SNRIs)

  • Certain blood pressure medicines

  • Alcohol

Important Drug Interaction Considerations

Other NSAIDs: Combining etodolac with ibuprofen, diclofenac, naproxen, or other NSAIDs increases the risk of gastrointestinal ulcers, bleeding, and kidney injury.

Aspirin: Concurrent use with aspirin may increase gastrointestinal bleeding risk. Patients taking low-dose aspirin for cardiovascular protection should not discontinue it without medical advice.

Anticoagulants: Etodolac may increase bleeding risk when combined with warfarin or other anticoagulants. Monitoring may be necessary.

Blood Pressure Medicines: Etodolac may reduce the effectiveness of ACE inhibitors, ARBs, and certain diuretics. These combinations may also increase the risk of kidney dysfunction.

Lithium: Etodolac may increase lithium concentrations and raise the risk of lithium toxicity.

Methotrexate: NSAIDs may reduce methotrexate clearance, potentially increasing its toxicity.

Cyclosporine and Tacrolimus: Concurrent use may increase the risk of kidney injury.

Corticosteroids: Combining etodolac with corticosteroids may increase the risk of gastrointestinal ulceration and bleeding.

SSRIs and SNRIs: Concurrent use with certain antidepressants may increase the risk of gastrointestinal bleeding.

Alcohol: Alcohol consumption may increase gastrointestinal irritation and bleeding risk during etodolac treatment.

Important: Some drug combinations should be avoided, while others require dose adjustments or monitoring. Inform your healthcare provider about all medicines you take before starting Etolid Tablet.

What should I watch for while using this medicine?

Seek immediate medical attention if you experience:

  • Severe chest pain

  • Sudden difficulty breathing

  • Sudden weakness or numbness on one side of the body

  • Difficulty speaking

  • Severe headache with neurological symptoms

  • Severe abdominal pain

  • Vomiting blood

  • Black or tarry stools

  • Severe allergic reactions

  • Swelling of the face, lips, tongue, or throat

  • Severe skin rash, blistering, or peeling

  • Significant reduction in urine output

  • Severe swelling of the legs or feet

  • Yellowing of the skin or eyes

  • Severe dizziness or fainting

  • Sudden worsening of heart failure symptoms

While using this medicine:

  • Monitor whether joint pain and swelling improve.

  • Report persistent or worsening symptoms.

  • Avoid taking additional NSAIDs without medical advice.

  • Monitor blood pressure regularly when recommended.

  • Report unusual swelling or fluid retention.

  • Maintain adequate hydration.

  • Inform your doctor about persistent stomach discomfort.

  • Report dizziness or excessive drowsiness.

  • Avoid driving if dizziness or impaired alertness occurs.

  • Follow the prescribed treatment duration.

  • Do not increase the dose independently.

  • Attend regular follow-up appointments for chronic arthritis.

  • Follow recommended kidney and liver function monitoring during prolonged treatment.

  • Report signs of gastrointestinal bleeding immediately.

  • Inform your physician if you develop chest pain or breathing difficulties.

  • Discuss appropriate physiotherapy and joint-protection measures.

  • Avoid smoking and excessive alcohol consumption.

  • Inform your doctor if pregnancy occurs or is suspected.

NOTE: Etodolac may cause serious gastrointestinal ulcers, bleeding, and perforation, sometimes without warning symptoms.

Prolonged NSAID use may also increase cardiovascular and kidney-related risks, particularly in patients with existing medical conditions.

Regular clinical monitoring helps determine whether continued treatment remains appropriate.

What side effects may I notice from this medicine?

Side effects that should be reported immediately:

  • Heart attack symptoms

  • Stroke-like symptoms

  • Severe allergic reactions

  • Difficulty breathing

  • Swelling of the face, lips, or throat

  • Gastrointestinal bleeding

  • Black or bloody stools

  • Severe stomach pain

  • Severe skin reactions, including Stevens-Johnson syndrome

  • Acute kidney injury

  • Significant reduction in urine output

  • Serious liver problems

  • Yellowing of the skin or eyes

  • Severe fluid retention

  • Sudden worsening of heart failure

  • Severe or persistent high blood pressure

  • Unusual bleeding or bruising

  • Severe weakness or fainting

Side effects that usually do not require medical attention:

  • Nausea

  • Vomiting

  • Mild abdominal pain

  • Indigestion

  • Heartburn

  • Diarrhoea

  • Constipation

  • Flatulence

  • Loss of appetite

  • Headache

  • Dizziness

  • Mild drowsiness

  • Fatigue

  • Mild stomach discomfort

  • Mild swelling of the feet or ankles

These side effects may be more noticeable when treatment begins or the dosage is increased.

Some effects may improve as the body adjusts to treatment.

Contact your healthcare provider if they persist, become troublesome, or worsen.

Important: Gastrointestinal discomfort, headache, dizziness, and fluid retention are recognized adverse effects of etodolac.

Severe abdominal pain, black stools, chest pain, breathing difficulties, or sudden neurological symptoms require immediate medical evaluation.

Where should I keep my medicine?

  • Keep out of the reach of children.

  • Store below 30°C according to available product information.

  • Keep the tablets in a cool, dry place.

  • Protect from excessive heat and moisture.

  • Protect from direct sunlight.

  • Keep tablets in their original blister packaging until use.

  • Avoid storing the medicine in bathrooms or excessively humid locations.

  • Do not use tablets after their expiry date.

  • Do not use tablets if the packaging is damaged.

  • Avoid transferring tablets into unlabelled containers.

  • Keep the medicine away from direct sources of heat.

  • Dispose of expired or unused tablets according to your pharmacist's instructions.

Storage Note: Tata 1mg lists storage below 30°C for Etolid Tablet ER. Follow the storage instructions printed on the original product packaging.

Manufacturer Details

Field

Information

Brand Name

Etolid Tablet

Generic Name

Etodolac

Strength

600 mg

Dosage Form

Oral Film-Coated Extended-Release Tablet

Therapeutic Class

Nonsteroidal Anti-Inflammatory Drug (NSAID) / Analgesic

Indication

Management of Pain and Inflammation Associated with Osteoarthritis and Rheumatoid Arthritis

Manufacturer / Marketer

Leeford Healthcare Limited

Prescription Status

Prescription Only Medicine

Storage

Store Below 30°C According to Retailer Listing; Follow Original Label

Route of Administration

Oral

Pack Size

1 × 10 Tablets

Packaging Type

Alu-Alu Blister Strip

Country of Origin

India

Last Updated on 12/11/2026

Medically Written ByDr. Marcus Vance, PharmDDr. Marcus Vance, PharmD

Last Updated on 12/11/2026

Medically Reviewed ByDr. Rachel Peter, PharmD, PhDDr. Rachel Peter, PharmD, PhD